(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||
Par Value Per Share |
(d) | Exhibits |
Exhibit Number | Description | ||||||||||
99.1 | |||||||||||
CARDIOVASCULAR SYSTEMS, INC. | ||||||||
By: | /s/ Jeffrey S. Points | |||||||
Jeffrey S. Points Chief Financial Officer |
Cardiovascular Systems, Inc. Jack Nielsen Vice President, Investor Relations & Corporate Communications (651) 202-4919 j.nielsen@csi360.com 1225 Old Highway 8 NW St. Paul, MN 55112 www.csi360.com |
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
Document and Entity Information |
Nov. 24, 2021 |
Apr. 01, 2020 |
---|---|---|
Cover [Abstract] | ||
Document Type | 8-K | |
Document Period End Date | Nov. 24, 2021 | |
Entity Registrant Name | CARDIOVASCULAR SYSTEMS, INC. | |
Entity Incorporation, State or Country Code | DE | |
Entity File Number | 000-52082 | |
Entity Tax Identification Number | 41-1698056 | |
Entity Address, Address Line One | 1225 Old Highway 8 Northwest | |
Entity Address, City or Town | St. Paul | |
Entity Address, State or Province | MN | |
Entity Address, Postal Zip Code | 55112-6416 | |
City Area Code | 651 | |
Local Phone Number | 259-1600 | |
Written Communications | false | |
Soliciting Material | false | |
Pre-commencement Tender Offer | false | |
Pre-commencement Issuer Tender Offer | false | |
Entity Emerging Growth Company | false | |
Title of 12(b) Security | Common Stock, One-tenth of One Cent ($0.001)Par Value Per Share | |
Trading Symbol | CSII | |
Security Exchange Name | NASDAQ | |
Entity Central Index Key | 0001180145 | |
Amendment Flag | false |
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end
$%]*WTQCF-.P&HW>;G/DS\W3YP]<$SS14
M'[L*89O-?0\3 I&H;A)!=WU)5T!\]U45F(@U15QSSU\1N7_J(N5+!\5$LW6#
MTP2T,1B1$-6FU!UGP15%#1^<)>B-##T$8H"8''Q>&]2'&Y3K#C-/!PDEOYZV
MS.UV[X?HJYYH>"K67$/'"G78;EG=Q)ZI$)&*DNFKH"V:NK;6FV_7>,:).8DA
M(CGMQ\/WG(_[$Y,SJ/W0/%'25=VT
M;OG?\FI=5(.G7GCTG1485RE,P@ND,R@2YUPI8!+BT)1L>=!O"XS^()"\7-Q7
M1J1+@,<9W'VGY86Q(CGBN<,VG7N+ET6ID'050#)OO2P&@.);F_TP&/%6Z(L%
M?.7 =W==EN>7=;5IL308=)AAFYTD9C/6W7XJ-"=4.&RUM&8(\P#!?VRW'P C
MW@'=2